Brunswick Corporation (NYSE:BC) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to Brunswick Corporation's Fourth Quarter and Full-year 2022 Earnings Conference Call.
Stay updated with breaking news from Analyst Event. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good morning, and welcome to Brunswick Corporation's Fourth Quarter and Full-year 2022 Earnings Conference Call.
COVID-19 vaccine sales for 2022 approximately $18.4 billion (unaudited)Reiterating 2023 expected minimum COVID-19 vaccine sales of approximately $5.0 billion; continue to expect additional contracts for
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced...
SAN FRANCISCO, Dec. 5, 2022 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that it will host an investor and analyst event on ...
Third quarter 2022 revenues of $3.4 billion; GAAP net income of $1.0 billion and GAAP diluted EPS of $2.53Revenue from advance purchase agreements for anticipated delivery in 2022 expected to be $18 to